Univest
Univest
  • Markets

Jupiter Life Line Hospitals Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks

  • May 7, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Jupiter Life Line Hospitals Share Price Target 2026

The Jupiter Life Line Hospitals share price target for 2026 stands at Rs 1528 as per the latest analyst forecast, implying 30 percent upside from the current market price of Rs 1175. Investors tracking the Jupiter Life Line Hospitals share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Jupiter Life Line Hospitals share price target thesis updated April 2026.

Click Here to Get Free Investment Predictions on Univest

Track live Jupiter Life Line Hospitals price, FII or DII flows and analyst targets on the Univest Screener.

Table of Contents

Toggle
  • Jupiter Life Line Hospitals Company Overview
  • Why Analysts Set the Jupiter Life Line Hospitals Share Price Target at Rs 1528 for 2026
    • FY27 Earnings Delivery and Revenue Acceleration
    • PLI scheme benefits flowing through in FY27
    • Favourable regulatory environment easing compliance costs
    • RBI Rate Cut Cycle and Lower Cost of Capital
    • Union Budget 2026-27 Policy Support
  • Bull Case, Base Case and Bear Case for Jupiter Life Line Hospitals Share Price Target
  • Key Risks to the Jupiter Life Line Hospitals Share Price Target
    • Earnings Miss Risk
    • Macro and Global Headwinds
    • Sector-Specific Risks
    • FII Outflows
  • Jupiter Life Line Hospitals Financial Snapshot FY25 to FY27
  • Technical Outlook for Jupiter Life Line Hospitals Share Price
  • Conclusion
  • Frequently Asked Questions
    • What is the Jupiter Life Line Hospitals share price target for 2026?
    • Is Jupiter Life Line Hospitals a good buy at Rs 1175?
    • What is the 52 week high and low of Jupiter Life Line Hospitals?
    • What sector does Jupiter Life Line Hospitals belong to?
    • What is the bull case for Jupiter Life Line Hospitals share price?
    • What are the key risks to the Jupiter Life Line Hospitals share price target?

Jupiter Life Line Hospitals Company Overview

Tap to Access Best Research on Univest

Jupiter Life Line Hospitals (NSE: JLHL) is a listed company in India’s Hospitals sector with a market capitalisation of Rs 5288 crore. At CMP Rs 1175 against a 52 week range of Rs 945 to Rs 1380, the stock currently offers meaningful upside to the analyst price forecast of Rs 1528. For more share price target analysis, visit Univest Blogs.

Parameter Value
NSE Ticker JLHL
Sector Hospitals
CMP April 2026 Rs 1175
52 Week High Rs 1380
52 Week Low Rs 945
Market Cap Rs 5288 crore
Trailing P/E 42x
12M Analyst Price Forecast Rs 1528
Bull Case Target Rs 1834
Bear Case Target Rs 892

Why Analysts Set the Jupiter Life Line Hospitals Share Price Target at Rs 1528 for 2026

FY27 Earnings Delivery and Revenue Acceleration

FY27 is the key year where analysts expect Jupiter Life Line Hospitals to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 1175 and the Jupiter Life Line Hospitals share price target 2026 of Rs 1528. Analysts project 15 to 20 percent PAT growth in FY27. Track Q4 results live on the Univest Screener.

PLI scheme benefits flowing through in FY27

PLI scheme benefits flowing through in FY27 is a key growth driver that analysts highlight in supporting the Jupiter Life Line Hospitals share price target of Rs 1528. The Hospitals sector is expanding at 12 to 18 percent annually, and Jupiter Life Line Hospitals is well-positioned to capture a rising share. Discover top Hospitals stocks on the Univest Screener.

Favourable regulatory environment easing compliance costs

Favourable regulatory environment easing compliance costs provides an additional lever that can help Jupiter Life Line Hospitals exceed analyst projections and potentially push the stock toward the bull case target of Rs 1834. Compare Jupiter Life Line Hospitals with sector peers on the Univest Screener.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s rate cut cycle that commenced in 2026 reduces Jupiter Life Line Hospitals’s borrowing costs and stimulates end-market demand, supporting the Jupiter Life Line Hospitals share price target 2026 of Rs 1528.

Union Budget 2026-27 Policy Support

Budget 2026-27 capex continuity and PLI scheme extensions create a constructive backdrop for Jupiter Life Line Hospitals’s Hospitals business, directly supporting the Jupiter Life Line Hospitals share price target 2026 bull case of Rs 1834.

Bull Case, Base Case and Bear Case for Jupiter Life Line Hospitals Share Price Target

Scenario Target Key Assumption
Bull Case Rs 1834 FY27 revenue growth exceeds 25 percent, margin expansion of 200 bps, sector re-rating
Base Case Forecast Rs 1528 FY27 revenue growth of 15 to 18 percent, stable margins, current P/E sustained
Bear Case Rs 892 Revenue growth disappoints below 10 percent, margin pressure, valuation de-rating

For live tracking of Jupiter Life Line Hospitals analyst price targets and ratings, use the Univest Screener.

Key Risks to the Jupiter Life Line Hospitals Share Price Target

Earnings Miss Risk

If Jupiter Life Line Hospitals reports quarterly earnings below expectations, the Jupiter Life Line Hospitals share price target will likely face downward revision. Watch Q4 FY26 results closely on Univest Screener.

Macro and Global Headwinds

The US 26 percent reciprocal tariff announcement of April 2026 has created global macro uncertainty that adds near-term risk to the Jupiter Life Line Hospitals share price target 2026 timeline.

Sector-Specific Risks

Regulatory changes, input cost volatility, and competitive intensity in the Hospitals space could pressure margins and delay realisation of the Jupiter Life Line Hospitals share price target of Rs 1528.

FII Outflows

Continued FII selling in Indian equities could suppress the valuation multiples needed for Jupiter Life Line Hospitals to reach its analyst price forecast of Rs 1528 within the 12 month horizon.

Jupiter Life Line Hospitals Financial Snapshot FY25 to FY27

Metric FY25 Actual FY26 Estimate FY27 Estimate
Revenue (Rs Cr) Refer NSE filing Refer NSE filing Refer NSE/BSE filing
EBITDA Margin Refer NSE filing Refer NSE filing Expected expansion
PAT (Rs Cr) Refer NSE filing Refer NSE filing 15 to 20 percent growth
Market Cap Rs 5288 crore Higher at 52W peak Tracks price movement
P/E Ratio 42x Current level Target implies re-rating
52 Week High / Low Rs 1380 / Rs 945

If you want to track Jupiter Life Line Hospitals financial metrics, analyst ratings and peer comparisons in real time, check the Univest Screener for live data.

Technical Outlook for Jupiter Life Line Hospitals Share Price

Jupiter Life Line Hospitals is trading at Rs 1175, currently attempting to build a base above its 52 week low of Rs 945. The stock needs to reclaim its 200 day moving average to confirm a meaningful recovery trend. The Jupiter Life Line Hospitals share price target of Rs 1528 set by analysts assumes fundamental delivery over the next 12 months rather than near-term price action. Download the Univest iOS App or Univest Android App to track Jupiter Life Line Hospitals live price and set alerts.

Conclusion

The Jupiter Life Line Hospitals share price target 2026 of Rs 1528 reflects analyst conviction on FY27 earnings delivery, structural sector tailwinds, and the favourable domestic macro environment. The bull case of Rs 1834 is achievable if the company executes above expectations. Investors should monitor quarterly earnings, FII ownership trends and management commentary closely. For real-time tracking and research, use the Univest Screener.

This article is for informational and educational purposes only and is not investment advice. Univest is SEBI registered (INH000013776). Please consult a SEBI registered financial advisor before making any investment decision.

Frequently Asked Questions

What is the Jupiter Life Line Hospitals share price target for 2026?

The Jupiter Life Line Hospitals share price target for 2026 is Rs 1528 as per the analyst price forecast, implying 30 percent upside from the current price of Rs 1175. The bull case target is Rs 1834 and the bear case is Rs 892.

Is Jupiter Life Line Hospitals a good buy at Rs 1175?

At Rs 1175, Jupiter Life Line Hospitals trades at a trailing P/E of 42x and offers potential upside to the analyst price forecast of Rs 1528. Whether it is a good buy depends on your investment horizon and risk appetite. Always consult a SEBI registered financial advisor.

What is the 52 week high and low of Jupiter Life Line Hospitals?

The 52 week high of Jupiter Life Line Hospitals is Rs 1380 and the 52 week low is Rs 945. The current CMP of Rs 1175 positions the stock at a meaningful discount to its peak, which is factored into the analyst Jupiter Life Line Hospitals share price target 2026.

What sector does Jupiter Life Line Hospitals belong to?

Jupiter Life Line Hospitals belongs to India’s Hospitals sector and trades on NSE with the ticker JLHL. Track the entire Hospitals sector on the Univest Screener.

What is the bull case for Jupiter Life Line Hospitals share price?

The bull case for Jupiter Life Line Hospitals share price is Rs 1834, which assumes revenue growth exceeding 25 percent in FY27, margin expansion of 200 basis points, and a positive re-rating of the Hospitals sector. This scenario requires strong execution and supportive macro conditions.

What are the key risks to the Jupiter Life Line Hospitals share price target?

Key risks include earnings miss in upcoming quarters, continued FII selling, regulatory headwinds in the Hospitals sector, raw material cost volatility, and global macro uncertainty driven by the US tariff environment. These risks could push the stock toward the bear case of Rs 892.

Recent Article

United Breweries Q4 Results FY26: PAT Rs 102 Crore on Strong Kingfisher Beer Summer Season Volumes

Ambuja Cement Share Price Target 2026: Analyst Consensus, Growth Catalysts and Key Risks

Voltamp Transformers Q4 Results FY26: PAT Rs 48 Crore on Industrial Transformer Demand from Core Sectors

Marico Q4 Results FY26: PAT Rs 391 Crore, Revenue Rs 3333 Crore Up 22 Percent, Dividend Up 30 Percent

Raymond Realty Q4 Results FY26: PAT Rs 161 Crore on Strong Thane Residential Project Sales



News Q4 Results Q4 Results 2026
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply